AssuredPartners Investment Advisors, LLC
Position in RLAY — Relay Therapeutics, Inc.
CIK 2055492
Tampa, FL
Position in RLAY
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$120,016
-$16,384 QoQ
Shares Held
12,062
-25.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AssuredPartners Investment Advisors, LLC holds $2,463,424 across 7 Biotechnology names. RLAY ranks #3 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,456 | $1,543,242 | |
| 2 | SPRY |
ARS Pharmaceuticals, Inc.
|
76,210 | $611,966 | |
| 3 | RLAY |
Relay Therapeutics, Inc.
This page
|
12,062 | $120,016 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
23,133 | $71,018 | |
| 5 | ABSI |
Absci Corp
|
16,084 | $48,252 | |
| 6 | ABCL |
AbCellera Biologics Inc.
|
12,281 | $42,860 | |
| 7 | LCTX |
Lineage Cell Therapeutics, Inc.
|
16,500 | $26,070 |
All Filings in RLAY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $120,016 | 12,062 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $136,400 | 16,123 | Shares | Sole | 2026-02-03 | |
| 2025-03-31 | $29,419 | 11,229 | Shares | Sole | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||